PMID- 35986391 OWN - NLM STAT- MEDLINE DCOM- 20220823 LR - 20220826 IS - 1297-9716 (Electronic) IS - 0928-4249 (Print) IS - 0928-4249 (Linking) VI - 53 IP - 1 DP - 2022 Aug 19 TI - A porcine reproductive and respiratory syndrome virus (PRRSV)-specific IgM as a novel adjuvant for an inactivated PRRSV vaccine improves protection efficiency and enhances cell-mediated immunity against heterologous PRRSV challenge. PG - 65 LID - 10.1186/s13567-022-01082-5 [doi] LID - 65 AB - Current strategies for porcine reproductive and respiratory syndrome (PRRS) control are inadequate and mainly restricted to immunization using different PRRS virus (PPRSV) vaccines. Although there are no safety concerns, the poor performance of inactivated PRRSV vaccines has restricted their practical application. In this research, we employed the novel PRRSV-specific IgM monoclonal antibody (Mab)-PR5nf1 as a vaccine adjuvant for the formulation of a cocktail composed of inactivated PRRSV (KIV) and Mab-PR5nf1 along with a normal adjuvant to enhance PRRSV-KIV vaccine-mediated protection and further compared it with a normal KIV vaccine and modified live virus vaccine (MLV). After challenge with highly pathogenic (HP)-PRRSV, our results suggested that the overall survival rate (OSR) and cell-mediated immunity (CMI), as determined by serum IFN-gamma quantification and IFN-gamma ELISpot assay, were significantly improved by adding PRRSV-specific IgM to the PRRSV-KIV vaccine. It was also notable that both the OSR and CMI in the Mab-PR5nf1-adjuvanted KIV group were even higher than those in the MLV group, whereas the CMI response is normally poorly evoked by KIV vaccines or subunit vaccines. Compared with those in piglets immunized with the normal KIV vaccine, viral shedding and serum neutralizing antibody levels were also improved, and reduced viral shedding appeared to be a result of enhanced CMI caused by the inclusion of IgM as an adjuvant. In conclusion, our data provide not only a new formula for the development of an effective PRRSV-KIV vaccine for practical use but also a novel method for improving antigen-specific CMI induction by inactivated vaccines and subunit vaccines. CI - (c) 2022. The Author(s). FAU - Chen, Rui AU - Chen R AD - Department of Preventive Veterinary Medicine, College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, China. FAU - Liu, Bing AU - Liu B AD - Department of Preventive Veterinary Medicine, College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, China. FAU - Zhang, Xiangmei AU - Zhang X AD - Department of Preventive Veterinary Medicine, College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, China. FAU - Qin, Mengmeng AU - Qin M AD - Department of Preventive Veterinary Medicine, College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, China. FAU - Dong, Jianhui AU - Dong J AD - Department of Preventive Veterinary Medicine, College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, China. FAU - Gu, Guoqian AU - Gu G AD - Department of Preventive Veterinary Medicine, College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, China. AD - Department of Infectious Diseases and Public Health, Jockey Club College of Veterinary Medicine, City University of Hong Kong, Hong Kong SAR, China. FAU - Wu, Chunyan AU - Wu C AD - Department of Preventive Veterinary Medicine, College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, China. FAU - Wang, Jingyu AU - Wang J AD - Department of Preventive Veterinary Medicine, College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, China. wjingyu2004@126.com. FAU - Nan, Yuchen AU - Nan Y AUID- ORCID: 0000-0002-4442-8004 AD - Department of Preventive Veterinary Medicine, College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, China. nanyuchen2015@nwsuaf.edu.cn. LA - eng GR - 2017YFD0501004/National Key Research and Development Program of China/ PT - Journal Article DEP - 20220819 PL - England TA - Vet Res JT - Veterinary research JID - 9309551 RN - 0 (Adjuvants, Immunologic) RN - 0 (Antibodies, Viral) RN - 0 (Immunoglobulin M) RN - 0 (Vaccines, Attenuated) RN - 0 (Vaccines, Inactivated) RN - 0 (Vaccines, Subunit) RN - 0 (Viral Vaccines) SB - IM MH - Adjuvants, Immunologic/pharmacology MH - Animals MH - Antibodies, Viral MH - Immunity, Cellular MH - Immunoglobulin M MH - *Porcine Reproductive and Respiratory Syndrome/prevention & control MH - *Porcine respiratory and reproductive syndrome virus MH - Swine MH - *Swine Diseases MH - Vaccines, Attenuated MH - Vaccines, Inactivated MH - Vaccines, Subunit MH - *Viral Vaccines PMC - PMC9389807 OTO - NOTNLM OT - IgM OT - PRRSV OT - broadly neutralizing antibody OT - inactivated PRRSV vaccine OT - monoclonal antibody OT - vaccine adjuvant COIS- The authors declare that they have no competing interests. EDAT- 2022/08/20 06:00 MHDA- 2022/08/24 06:00 PMCR- 2022/08/19 CRDT- 2022/08/19 23:41 PHST- 2022/04/30 00:00 [received] PHST- 2022/06/30 00:00 [accepted] PHST- 2022/08/19 23:41 [entrez] PHST- 2022/08/20 06:00 [pubmed] PHST- 2022/08/24 06:00 [medline] PHST- 2022/08/19 00:00 [pmc-release] AID - 10.1186/s13567-022-01082-5 [pii] AID - 1082 [pii] AID - 10.1186/s13567-022-01082-5 [doi] PST - epublish SO - Vet Res. 2022 Aug 19;53(1):65. doi: 10.1186/s13567-022-01082-5.